Vitamin c and immunotherapy combo tested in lung cancer window trial
Knowledge-focused
Terminated
This early-phase trial tested whether combining high-dose vitamin C with the immunotherapy drug durvalumab could boost the immune system's attack on non-small cell lung cancer before surgery. Only one person took part before the study was stopped. The main goal was to measure imm…
Phase: PHASE1 • Sponsor: William Zeitler • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC